← FDA Drug Approvals (Drugs@FDA)

RABEPRAZOLE SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2013-11-08

Drug application

FDA Application #

ANDA076822

Application type

Abbreviated New Drug Application (Generic)

Brand name

RABEPRAZOLE SODIUM

Generic name

Rabeprazole Sodium

Active ingredients

RABEPRAZOLE SODIUM

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

TEVA PHARMS USA

First approval

2013-11-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown